PATENT CLAIM ANALYSIS

Application Number: 16081818
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-05
Patent Classification: ["514", "04400A"]

Abstract:
Methods of inhibiting influenza A virus in a sample are provided. Aspects of the methods include contacting a sample comprising viral RNA (vRNA) having a PSL2 motif with an effective amount of an agent that specifically binds the PSL2 motif to inhibit the influenza A virus. Also provided are methods of treating or preventing influenza A virus infection in a subject. Also provided are methods for screening a candidate agent for the ability to inhibit influenza A virus in a cell, the method comprising: contacting a sample with a candidate agent; and determining whether the candidate agent specifically binds to the PSL2 motif of vRNA. Also provided are compounds and pharmaceutical compositions comprising an oligonucleotide sequence complementary to a PB2 vRNA region that find use in the subject methods.

Claim (Index 4):
The compound of  claim 1 , wherein the oligonucleotide comprises a locked nucleic acid (LNA) nucleotide.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 96.0
- Lexical Diversity: 2.17188
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15203581', '15865364', '14699213', '13594611', '14332121']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6701989318614422
- 35 USC 102 Novelty (BERT): 0.5231093701900544
- Combined Prediction Score: 0.6554899756943035
- Mean Citation Score: 298.882436
- Max Citation Score: 305.1271700000001
- Similarity Product: 201.0444435371352

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test